يعرض 1 - 10 نتائج من 531 نتيجة بحث عن '"de Sanjosé, S"', وقت الاستعلام: 1.58s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    الوصف: It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية

    المساهمون: Garcia-Martin, P., Diez, A. M., Maldonado, J. M. S., Serrano, A. J. C., ter Horst, R., Benavente, Y., Landi, S., Macauda, A., Clay-Gilmour, A., Hernandez-Mohedo, F., Niazi, Y., Gonzalez-Sierra, P., Espinet, B., Rodriguez-Sevilla, J. J., Maffei, R., Blanco, G., Giaccherini, M., Puiggros, A., Cerhan, J., Marasca, R., Canadas-Garre, M., Lopez-Nevot, M. A., Chen-Liang, T., Thomsen, H., Gamez, I., Moreno, V., Marcos-Gragera, R., Garcia-Alvarez, M., Llorca, J., Jerez, A., Berndt, S., Butrym, A., Norman, A. D., Casabonne, D., Luppi, M., Slager, S. L., Hemminki, K., Li, Y., Alcoceba, M., Campa, D., Canzian, F., de Sanjose, S., Forsti, A., Netea, M. G., Jurado, M., Sainz, J.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35581176; info:eu-repo/semantics/altIdentifier/wos/WOS:000796960500001; volume:12; issue:5; firstpage:79; lastpage:N/A; journal:BLOOD CANCER JOURNAL; http://hdl.handle.net/11380/1288026Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85130175544

  6. 6
    دورية أكاديمية

    الوصف: Background The proportion of women infected with human papillomavirus (HPV) varies greatly across populations, as might the distribution of HPV types. We aimed to compare HPV-type distribution in representative samples of women from different world regions. ; Methods Women were randomly selected from the general population of 13 areas from 11 countries (Nigeria, India, Vietnam, Thailand, Korea, Colombia, Argentina, Chile, the Netherlands, Italy, and Spain). A standardised protocol was used for cervical specimen collection. All HPV testing was by GP5+/6+ PCR-based EIA. The proportion of HPV-positive women infected with different HPV types was compared by study area and between pooled regions with age-adjusted odds ratios (ORs) with corresponding 95% floating CIS. ; Findings 15 613 women aged 15-74 years without cytological abnormalities were included in a pooled analysis. Age-standardised HPV prevalence varied nearly 20 times between populations, from 1.4% (95% CI 0.5-2.2) in Spain to 25.6% (22.4-28.8) in Nigeria. Although both overall HPV prevalence and HPV16 prevalence were highest in sub-Saharan Africa, HPV-positive women in Europe were significantly more likely to be infected with HPV16 than were those in sub-Saharan Africa (OR 2.64, p=0.0002), and were significantly less likely to be infected with high-risk HPV types other than HPV16 (OR 0.57, p=0.004) and/or low-risk HPV types (OR 0.44. p=0.0002). Women from South America had HPV-type distribution in between those from sub-Saharan Africa and Europe. Heterogeneity between areas of Asia was significant. ; Interpretation Heterogeneity in HPV type distribution among women from different populations should be taken into account when developing screening tests for the virus and predicting the effect of vaccines on the incidence of infection.

    وصف الملف: 8 páginas; application/pdf

    العلاقة: MEDLINE:16168781; https://doi.org/10.1016/S0140-6736Test(05)67069-9; https://repositorio.uc.cl/handle/11534/79944Test; WOS:000231955900034

  7. 7
    دورية أكاديمية

    الوصف: Human papillomavirus (HPV) is a sexually transmitted infection but it is unclear whether differences in transmission efficacy exist between individual HPV types. Information on sexual behavior was collected from 11 areas in four continents among population-based, age-stratified random samples of women of ages >= 5 years. HPV testing was done using PCR-based enzyme immunoassay. Unconditional logistic regression was used to estimate odds ratios (OR) of being HPV positive and corresponding 95% confidence intervals (95% CI). Variables were analyzed categorically. When more than two groups were compared, floating confidence intervals were estimated by treating ORs as floating absolute risks. A total of 11,337 women (mean age, 41.9 years) were available. We confirmed that lifetime number of sexual partners is associated with HPV positivity (OR for >= 2 versus 1, 1.86; 95% CI, 1.63-2.11) but the association was not a linear one for HPV18,31, and 33 (i.e., no clear increase for >= 3 versus 2 sexual partners). Women who had multiple-type infection and highrisk HPV type infection reported a statistically nonsignificant higher number of sexual partners than women who had single-type and low-risk type infections, respectively. Early age at sexual debut was not significantly related to HPV positivity. Husband's extramarital sexual relationships were associated with an OR of 1.45 (95% CI, 1.24-1.70) for HPV positivity in their wives after adjustment for age and lifetime number of women's sexual partners. We did not observe a significant association with condom use. Our study showed an effect of both women's and their husbands' sexual behavior on HPV positivity. Furthermore, it suggests some differences in the pattern of the association between sexual behavior and different HPV types.

    وصف الملف: 8 páginas

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المساهمون: Satta, G., Loi, M., Becker, N., Benavente, Y., De Sanjose, S., Foretova, L., Staines, A., Maynadie, M., Nieters, A., Meloni, F., Pilia, I., Campagna, M., Pau, M., Zablotska, L. B., Cocco, P.

    الوصف: Background: Evidence linking risk of lymphoma and B-cell lymphoma subtypes to ionizing radiation is inconclusive, particularly at low exposure levels. Methods: We investigated risk of lymphoma (all subtypes), B-cell lymphomas, and its major subtypes, associated with low-level occupational exposure to ionizing radiation, in 2346 lymphoma cases and 2463 controls, who participated in the multicenter EpiLymph case-control study. We developed a job-exposure matrix to estimate exposure to ionizing radiation, distinguishing between internal and external radiation, and we applied it to the lifetime occupational history of study subjects, We calculated the Odds Ratio (OR) and its 95% confidence interval (95% CI) for lymphoma (all subtypes combined), B-cell lymphoma, and its major subtypes using unconditional, polytomous logistic regression adjusting for age, gender, and education. Results: We did not observe an association between exposure metrics of external and internal radiation and risk of lymphoma (all subtypes), nor with B-cell lymphoma, or its major subtypes, at the levels regularly experienced in occupational settings. An elevated risk of diffuse large B cell lymphoma was observed among the most likely exposed study subjects with relatively higher exposure intensity, which would be worth further investigation. Conclusions: Further investigation is warranted on risk of B cell lymphoma subtypes associated with low-level occupational exposure to external ionizing radiation, and to clarify whether lymphoma should be included among the cancer outcomes related to ionizing radiation.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32334593; info:eu-repo/semantics/altIdentifier/wos/WOS:000529993200001; volume:19; issue:1; numberofpages:11; journal:ENVIRONMENTAL HEALTH; http://hdl.handle.net/11584/301435Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85084030609; https://ehjournal.biomedcentral.com/articles/10.1186/s12940-020-00596-9Test

  10. 10
    دورية أكاديمية

    المساهمون: Moore A., Kane E., Wang Z., Panagiotou O.A., Teras L.R., Monnereau A., Wong Doo N., Machiela M.J., Skibola C.F., Slager S.L., Salles G., Camp N.J., Bracci P.M., Nieters A., Vermeulen R.C.H., Vijai J., Smedby K.E., Zhang Y., Vajdic C.M., Cozen W., Spinelli J.J., Hjalgrim H., Giles G.G., Link B.K., Clavel J., Arslan A.A., Purdue M.P., Tinker L.F., Albanes D., Ferri G.M., Habermann T.M., Adami H.-O., Becker N., Benavente Y., Bisanzi S., Boffetta P., Brennan P., Brooks-Wilson A.R., Canzian F., Conde L., Cox D.G., Curtin K., Foretova L., Gapstur S.M., Ghesquieres H., Glenn M., Glimelius B., Jackson R.D., Lan Q., Liebow M., Maynadie M., McKay J., Melbye M., Miligi L., Milne R.L., Molina T.J., Morton L.M., North K.E., Offit K., Padoan M., Patel A.V., Piro S., Ravichandran V., Riboli E., de Sanjose S., Severson R.K., Southey M.C., Staines A., Stewart C., Travis R.C., Weiderpass E., Weinstein S., Zheng T., Chanock S.J., Chatterjee N., Rothman N., Birmann B.M., Cerhan J.R., Berndt S.I.

    الوصف: Although the evidence is not consistent, epidemiologic studies have suggested that taller adult height may be associated with an increased risk of some non-Hodgkin lymphoma (NHL) subtypes. Height is largely determined by genetic factors, but how these genetic factors may contribute to NHL risk is unknown. We investigated the relationship between genetic determinants of height and NHL risk using data from eight genome-wide association studies (GWAS) comprising 10,629 NHL cases, including 3,857 diffuse large B-cell lymphoma (DLBCL), 2,847 follicular lymphoma (FL), 3,100 chronic lymphocytic leukemia (CLL), and 825 marginal zone lymphoma (MZL) cases, and 9,505 controls of European ancestry. We evaluated genetically predicted height by constructing polygenic risk scores using 833 height-associated SNPs. We used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) for association between genetically determined height and the risk of four NHL subtypes in each GWAS and then used fixed-effect meta-analysis to combine subtype results across studies. We found suggestive evidence between taller genetically determined height and increased CLL risk (OR = 1.08, 95% CI = 1.00–1.17, p = 0.049), which was slightly stronger among women (OR = 1.15, 95% CI: 1.01–1.31, p = 0.036). No significant associations were observed with DLBCL, FL, or MZL. Our findings suggest that there may be some shared genetic factors between CLL and height, but other endogenous or environmental factors may underlie reported epidemiologic height associations with other subtypes.

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32064237; info:eu-repo/semantics/altIdentifier/wos/WOS:000514376100001; volume:9; firstpage:1; lastpage:8; numberofpages:8; journal:FRONTIERS IN ONCOLOGY; http://hdl.handle.net/11585/732597Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85079502127; https://www.frontiersin.org/journals/oncologyTest